Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
pay day loan
Popular Articles

Oakland, Calif., Conference Targets Black Women For HIV/AIDS Awareness, Prevention
The Oakland, Calif., chapter of the National Coalition of 100 Black Women on Saturday held a daylong conference, "Sistahs Getting Real About HIV/AIDS," that addressed HIV/AIDS among black women, the San Francisco Chronicle reports. The conference "focused on two issues that might seem contradictory: first, to convince women that they must take special precautions to protect themselves, and second, to let them know that an HIV diagnosis is not a death sentence," according to the Chronicle. Keynote speaker of the conference Tony Wafford, director of health and wellness for the National Action Network, said black women need to be more vocal with their partners about practicing safe sex and getting tested for HIV. Organizers noted that black women also "must address the stigma associated with HIV before they can talk openly about the risk of infection with their partners," the article states (Allday, 7/25).
Underworld
Allergy Season: Cigarettes To The Rescue?
Everyone knows that smoking can kill you, but did you know that it may help with your allergies? A new study shows that cigarette smoke can prevent allergies by decreasing the reaction of immune cells to allergens.
News of the day
New Broad-Spectrum Vaccine To Prevent Cervical Cancer Induces Strong Responses In Animals
Mice and rabbits immunized with a multimeric-L2 protein vaccine had robust antibody responses and were protected from infection when exposed to human papillomavirus (HPV) type 16 four months after vaccination, according to a new study published in the May 26 online issue of the Journal of the National Cancer Institute.
Mental Health

Merck Partners With Non-Profit For Neglected Diseases Initiative

The pharmaceutical company, Merck, announced Monday it was partnering with the non-profit Drugs for Neglected Diseases initiative (DNDi) in an effort to improve treatments for neglected tropical diseases (NTD), the AP/CNBC reports. "The agreement covers drug candidates for illnesses like visceral leishmaniasis and Chagas disease, potentially lethal parasitic illnesses spread by insects. Current treatment for those illnesses may be toxic, or very expensive, or difficult to administer, Merck said," AP/CNBC writes (AP/CNBC, 6/22). RTT News reports, "Under terms of the agreement, Merck will contribute small molecule assets and related intellectual property via a non-exclusive, royalty-free license to DNDi to conduct early development programs for drug candidates for the treatment of NTDs like visceral leishmaniasis and Chagas disease" (RTT News, 6/22). In related news, Xinhua/CRIENGLISH.com reports on an international NTD meeting to be held Tuesday in Nairobi, Kenya. The meeting - sponsored by DNDi - will bring together researchers, clinicians and policymakers from around the world to discuss the latest research and drug development for NTD. "The meeting will also cement DNDi"s partnership with key players such as NGOs and leading African and international experts on infectious and neglected tropical diseases, according to Dr. Monique Wasunna, the assistant director," the news agency reports (Xinhua/CRIENGLISH.com, 6/22). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009